Influence of NPM1 and FLT3-ITD status on outcome in relapsed/refractory AML patients receiving salvage therapy including gemtuzumab ozogamicin. Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K [Leukemia] Journal article | | Title | Influence of NPM1 and FLT3-ITD status on outcome in relapsed/refractory AML patients receiving salvage therapy including gemtuzumab ozogamicin. | | Author(s) | Chevallier P, Prebet T, Pigneux A, Hunault M, Delaunay J, Perry F, Lode L, Richebourg S, Blanchet O, Vey N, Ifrah N, Milpied N, Blaise D, Harousseau JL, Mohty M | | Institution | [1] Service d'Hématologie Clinique, CHU, Nantes, France [2] Université de Nantes, INSERM U892, Nantes, France. | | Source | Leukemia 2009 Oct 22. | | Language | ENG | | Pub Type(s) | JOURNAL ARTICLE
| | PubMed ID | 19847200 |
|
|
| |
Advertise on this site.
| | |
|
